Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression

Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression
复制标题

醛脱氢酶 1 (ALDH1) 通过 MEK-1 表达的转录后调节促进 TRAIL 在非小细胞肺癌细胞中的毒性

DOI:
10.1159/000495202
复制
发表时间:
2018-11
期刊:
Cell Physiol Biochem
影响因子:
--
通讯作者:
夏蒲
夏蒲
中科院分区:
其他
文献类型:
--
作者:
夏蒲

文献摘要

参考文献

相似文献

背景/目的:基于肿瘤坏死因子相关凋亡诱导配体(TRAIL)的治疗已被用于许多人类癌症。然而,一些肿瘤对TRAIL诱导的细胞死亡具有抗性。乙醛脱氢酶1(ALDH 1)是鉴定CSC的功能性标志物。研究方法:本研究采用殖民地形成实验、AnnexinV/ PI双染及PI染色法检测TRAIL对ALDH 1+非小细胞肺癌(non-small cell lung cancer,NSCLC)细胞增殖、凋亡及细胞周期的影响。此外,我们建立了异种移植小鼠模型,以证实TRAIL在体内的抗肿瘤作用。最后,采用基因芯片和western blot检测ALDH 1 + NSCLC细胞对TRAIL敏感性的深层次机制。结果:TRAIL能抑制ALDH 1 + NSCLC细胞的增殖,诱导细胞凋亡和G1期阻滞。相应地,TRAIL与肿瘤大小减小和ALDH 1+细胞建立的异种移植小鼠模型的有利存活率相关。ALDH 1可通过激活MEK/ERK信号通路,增加ALDH 1 + NSCLC细胞死亡受体(DR)4和DR 5的表达。结论:ALDH 1蛋白可诱导MEK-1 mRNA的稳定性,并通过其3 'UTR促进MEK-1的翻译。
Background/Aim: Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)-based therapies have been used in many human cancers. However, some tumors are resistant to TRAIL-induced cell death. Aldehyde dehydrogenase 1 (ALDH1) is a functional marker for identification of CSCs. Methods: In this study, we used the colony formation assay, AnnexinV/ PI double staining and PI staining to detect proliferation, apoptosis and cell cycle in ALDH1+ non-small cell lung cancer (NSCLC) cells with TRAIL treatment. In addition, we established xenograft mouse models to confirm the anti-tumor roles of TRAIL in vivo. Finally, gene array and western blot were used to detect the deeper mechanism of the susceptibility of ALDH1+ NSCLC cells to TRAIL. Results: We confirmed that TRAIL could inhibit proliferation, and induce apoptosis and G1 arrest in ALDH1+ NSCLC cells. Correspondingly, TRAIL was associated with decreased tumor size and the favorable survival rate of ALDH1+ cells established xenograft mouse models. ALDH1 could increase the death receptors (DR) 4 and DR5 expression in ALDH1+ NSCLC cells via activating MEK/ERK signaling pathway. Conclusion: ALDH1 protein induced MEK-1 mRNA stability and promoted its translation via its 3’UTR.
DOI: 10.18632/genesandcancer.148
发表时间: 2017-07
期刊: Genes & cancer
影响因子: --
作者:
Nozaki Y;Tamori S;Inada M;Katayama R;Nakane H;Minamishima O;Onodera Y;Abe M;Shiina S;Tamura K;Kodama D;Sato K;Hara Y;Abe R;Takasawa R;Yoshimori A;Shinomiya N;Tanuma SI;Akimoto K
通讯作者: Akimoto K
DOI: 10.1093/nar/gkv493
发表时间: 2015-07-01
影响因子: 14.9
作者:
Tuszynska I;Magnus M;Jonak K;Dawson W;Bujnicki JM
通讯作者: Bujnicki JM
BAG3 直接稳定己糖激酶 2 mRNA 并促进胰腺癌细胞中的有氧糖酵解
DOI: 10.1083/jcb.201701064
发表时间: 2017-12-04
期刊: The Journal of cell biology
影响因子: --
作者:
An MX;Li S;Yao HB;Li C;Wang JM;Sun J;Li XY;Meng XN;Wang HQ
通讯作者: Wang HQ
透明质酸接枝 PEI-PLGA 纳米颗粒共同递送藤黄酸和 TRAIL 质粒用于治疗三阴性乳腺癌。
DOI: 10.1080/10717544.2017.1406558
发表时间: 2017-11
期刊: Drug delivery
影响因子: 6
作者:
Wang S;Shao M;Zhong Z;Wang A;Cao J;Lu Y;Wang Y;Zhang J
通讯作者: Zhang J
DOI: 10.18632/oncotarget.23684
发表时间: 2018-01-12
期刊: Oncotarget
影响因子: --
作者:
Awasthi N;Monahan S;Stefaniak A;Schwarz MA;Schwarz RE
通讯作者: Schwarz RE